Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools

Journal of Developmental Origins of Health and Disease

Volumn 3, Issue 4, 2012, Pages 216-223

  Hotham, E ^a   White, J ^a   Ali, R ^b   Robinson, J ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Pregnancy; Screening; Self report; Substance use

Indexed keywords

EID: 84883449455     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174412000372     Document Type: Article

References (68)

1. World Health Organization (WHO). The Global Burden of Disease: 2004 Update, 2008. WHO: Geneva.
2. Begg S, Vos T, Barker B, et al. The Burden of Disease and Injury in Australia 2003; PHE 82, 2007. Australian Institute of Health and Welfare: Canberra.
3. Windsor R. Smoking, Cessation and Pregnancy. Women and the Tobacco Epidemic Challenges for the 21st Century, 1999. World Health Organization: Geneva.
4. WHO. Gender, Health and Tobacco, 2003. WHO: Geneva. Retrieved 27 November 2011, from http://www.who.int/gender/documents/Gender-Tobacco-2.pdf
5. British Medical Association and Board of Science and Education and the Tobacco Control Centre. Smoking and reproductive life. The impact of smoking on sexual, reproductive and child health, 2004. Last update 20 November 2007. Retrieved 27 November 2011, from http://www.bma.org.uk/ images/smoking-tcm41- 21289.pdf
6. Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. J Am Med Assoc. 2003; 290, 2996-2999. (Pubitemid 37505533)
7. Fergusson DM, Horwood LJ, Northstone K, et al. Maternal use of cannabis and pregnancy outcome. BJOG: Int J Obstet Gynaecol. 2002; 109, 21-27.
8. Dawe S, Harnett P, Frye S. Improving Outcomes for Children Living in Families with Parental Substance Misuse: What Do We Know and What Should We Do, 2008. Child Abuse Prevention Issues No. 29. Australian Institute of Family Studies: Canberra.
9. Barker D. Human growth and cardiovascular disease. Nestlé Nutrition Workshop Series Pediatric Program: The Window of Opportunity: Pre-Pregnancy to 24 Months of Age, 2008. Nestec Ltd, Vevey/S. Karger AG: Basel, Switzerland.
10. Chudley AE, Conry J, Cook JL, et al. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. Can Med Assoc J. 2005; 172(Suppl. 5); S1-S21. (Pubitemid 40342084)
11. Bowling A. Measuring Health: A Review of Quality of Life Measurement Scales, 1997. Open University Press: Buckingham, Philadelphia.
12. Australian Institute of Health and Welfare (AIHW). Statistics on Drug Use in Australia 2006, 2007. Drug Statistics Series No. 18. Catalogue no. PHE 80. AIHW: Canberra.
13. Hotham E, Ali R, White J, et al. Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia. Aust N Z J Obstet Gynaecol. 2008; 48, 248-254. (Pubitemid 351798359)
14. Jacobson SW, Jacobson JL, Sokol RJ, et al. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol. 1991; 13, 535-540.
15. Poole N, Dell C. Girls, Women and Substance Use, 2005. Canadian Centre on Substance Abuse: Ottawa.
16. Russell M, Martier SS, Sokol RJ, et al. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 1996; 86, 1435-1439. (Pubitemid 26346605)
17. Savage C, Wray J, Ritchey P, et al. Current screening instruments related to alcohol consumption in pregnancy and a proposed alternative method. J Obstet Gynecol Neonatal Nurs. 2003; 32, 437-446.
18. New South Wales (NSW) Department of Health. Background Papers to the National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn, 2006. 172, NSW Department of Health: Sydney.
19. Alexander D. A review of marijuana assessment dilemmas: time for marijuana specific screening methods? J Soc Work Pract Addict. 2003; 3, 5-28.
20. Burd L, Martsolf J, Klug MG, et al. Prenatal alcohol exposure assessment: multiple embedded measures in a prenatal questionnaire. Neurotoxicol Teratol. 2003; 25, 675-679. (Pubitemid 37415153)
21. Lindenberg C, Strickland O, Solorzano R, et al. Correlates of alcohol and drug use among low-income Hispanic immigrant childbearing women living in the USA. Int J Nurs Stud. 1999; 36, 3-11.
22. Tobin M. Lost Opportunity or Lifeline? Women with substance use issues and their perceptions of the barriers to pregnancy care. A report on research conducted for the Women's Alcohol & Drug Services, 2005. Women's Alcohol and Drug Service, The Royal Women's Hospital: Melbourne.
23. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989; 160, 863-868.
24. Chang G. Alcohol-screening instruments for pregnant women. Alcohol Res Health. 2001; 25, 204-209. (Pubitemid 33708984)
25. Russell M. New assessment tools for risk drinking during pregnancy. Alcohol Health Res World. 1994; 18, 55-62.
26. Chasnoff IJ, McGourty RF, Bailey GW, et al. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol. 2005; 25, 368-374. (Pubitemid 40862199)
27. Kaskutas LA, Graves K. Pre-pregnancy drinking: how drink size affects risk assessment. Addiction. 2001; 96, 1199-1209. (Pubitemid 32738398)
28. Clark KA, Dawson S, Martin SL. The effect of implementing a more comprehensive screening for substance use among pregnant women in North Carolina. Matern Child Health J. 1999; 3, 161-166.
29. Chiodo LM, Sokol RJ, Delaney-Black , et al. Validity of the T-ACE in pregnancy in predicting child outcome and risk drinking. Alcohol. 2010; 44, 595-603.
30. Bad Heart Bull L, Kvigne V, Leonardson GR, et al. Validation of a self-administered questionnaire to screen for prenatal alcohol use in Northern Plains Indian women. Am J Prev Med. 1999; 16, 240-243. (Pubitemid 29152574)
31. Chasnoff IJ, Neuman K, Thornton C, et al. Screening for substance use in pregnancy: a practical approach for the primary care physician. Am J Obstet Gynecol. 2001; 184, 752-758. (Pubitemid 32234995)
32. Kennedy C, Finkelstein N, Hutchins E, et al. Improving screening for alcohol use during pregnancy: the Massachusetts ASAP Program. Matern Child Health J. 2004; 8, 137-147.
33. Kharrazi M, Epstein D, Hopkins B, et al. Evaluation of four maternal smoking questions. Public Health Rep. 1999; 114, 60-69.
34. Fagerstrom K. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. J Behav Med. 1978; 3, 235-241.
35. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991; 86, 1119-1127.
36. Tate JC, Schmitz JM. A proposed revision of the Fagerstrom Tolerance Questionnaire. Addict Behav. 1993; 18, 135-143. (Pubitemid 23106557)
37. Dolan-Mullen PD, Carbonari JP, Tabak ER, et al. Improving disclosure of smoking by pregnant women. Am J Obstet Gynecol. 1991; 165, 409-413.
38. Project Team: Mercy Hospital for Women Southern Health and Women's and Children's Health. Three Centres Consensus Guidelines on Antenatal Care, 2001. Mercy Hospital for Women, Southern Health Service and Womens' and Children's Health Service: Melbourne.
39. Hotham E, Gilbert A, Atkinson E. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav. 2006; 31, 641-648.
40. Handel G, Hannover W, Roske K, et al. Intention to change smoking in pregnant and postpartum women according to number of pregnancies. Eur J Public Health. 2009; 19, 218-221.
41. Midanik LT, Zahnd EG, Klein D. Alcohol and drug CAGE screeners for pregnant, low-income women: The California Perinatal Needs Assessment. Alcohol Clin Exp Res. 1998; 22, 121-125. (Pubitemid 28139204)
42. Sobell LC, Sobell MB. Timeline FollowBack: a technique for assessing self-reported alcohol consumption. In Measuring Alcohol Consumption Psychosocial and Biochemical Methods (eds. Litten R, Allen J), 1992; pp. 41-69. Humana Press: Totowa, NJ, USA.
43. Duhig AM, Cavallo DA, McKee SA, et al. Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addict Behav. 2005; 30, 271-283. (Pubitemid 40037996)
44. Horrigan T, Piazza N, Weinstein L. The substance abuse subtle screening inventory is more cost effective and has better selectivity than urine toxicology for the detection of substance abuse in pregnancy. J Perinatol. 1996; 16, 326-330. (Pubitemid 126432835)
45. Feldstein S, Miller W. Does subtle screening for substance abuse work? A review of the Substance Abuse Subtle Screening Inventory (SASSI). Addiction. 2007; 102, 41-50. (Pubitemid 46006470)
46. Miller CS, Woodson J, Howell RT, et al. Assessing the reliability of scores produced by the substance abuse subtle screening inventory. Subst Use Misuse. 2009; 44, 1090-1100.
47. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R, 1990. American Psychiatric Press: Washington, DC.
48. Alexander D, Leung P. The Marijuana Screening Inventory (MSI-X): reliability, factor structure, and scoring criteria with a clinical sample. Am J Drug Alcohol Abuse. 2004; 30, 321-351. (Pubitemid 38781288)
49. Kelly RH, Zatzick DF, Anders TF. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am J Psychiatry. 2001; 158, 213-219. (Pubitemid 32116518)
50. Sobell LC, Brown J, Leo GI, et al. The reliability of the Alcohol Timeline FollowBack when administered by telephone and by computer. Drug Alcohol Depend. 1996; 42, 49-54. (Pubitemid 26300639)
51. Weinstock J, Whelan J, Meyers AW, et al. Behavioral assessment of gambling: an application of the Timeline FollowBack method. Psychol Assess. 2004; 16, 72-80. (Pubitemid 38339685)
52. Project Choices Research Group. Alcohol-exposed pregnancy: characteristics associated with risk. Am J Prev Med. 2002; 23, 166-173.
53. Ndetei DM, Khasakhala LI, Ongecha-Owuor FA, et al. Prevalence of substance abuse among patients in general medical facilities in Kenya. Subst Abuse. 2009; 30, 182-190.
54. Holmwood C, Marriott M, Humeniuk R. Substance use patterns in newly admitted male and female South Australian prisoners using the WHO-ASSIST (Alcohol, Smoking and Substance Involvement Screening Test). Int J Prison Health. 2008; 4, 198-207.
55. Hotham E. Investigation of the Alcohol, Smoking and Substance Involvement Screening Test (The ASSIST) in pregnancy. The Australasian Digital Thesis Program, 2010. Retrieved 27 November 2011, from http://digital.library. adelaide.edu.au/dspace/handle/2440/60650
56. Humeniuk R, Ali R, Babor TF, et al. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Addiction. 2008; 103, 1039-1047. (Pubitemid 351703468)
57. Boston University School of Public Health, "Do I have a drug problem?" Questionnaire based on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Join Together Project. Retrieved 27 November 2011, from http://www. drugscreening.org/
58. Humeniuik R, Holmood C. Developing the E-ASSIST: the Alcohol, Smoking and Substance Involvement Screening Test questionnaire in electronic format for Australian clinicians. Drug Alcohol Rev. 2011; 30(Suppl. 1), 41-42.
59. Ostrea EM Jr, Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr. 2001; 138, 344-348. (Pubitemid 32207135)
60. Benowitz N. The use of biologic fluid samples in assessing tobacco smoke consumption. In NIDA Research Monograph, Vol. 48 (eds. Grabowski J, Bell C), 1983; 6-26. National Institute of Drug Abuse, Department of Health and Human Services: Rockville, MD, USA.
61. Pickett K, Rathouz P, Kasza K, et al. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol. 2005; 19, 368-376. (Pubitemid 41232385)
62. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002; 301, 594-598. (Pubitemid 34429972)
63. Stoler JM, Huntington KS, Peterson CM, et al. The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr. 1998; 133, 346-352. (Pubitemid 28413615)
64. Stauber R, Jauk B, Fickert P, et al. Increased carbohydratedeficient transferrin during pregnancy: relation to sex hormones. Alcohol Alcohol. 1996; 31, 389-392. (Pubitemid 26302570)
65. Conigrave KM, Davies P, Haber P, et al. Traditional markers of excessive alcohol use. Addiction. 2003; 98(Suppl. 2), 31-43. (Pubitemid 38030760)
66. Neumann T, Spies C. Use of biomarkers for alcohol use disorders in clinical practice. Addiction. 2003; 98(Suppl. 2), 81-91. (Pubitemid 38030765)
67. Burns L, Mattick R, Wallace C. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders. Nicotine Tob Res. 2008; 10, 969-974. (Pubitemid 351998433)
68. Corse SJ, Smith M. Reducing substance abuse during pregnancy: discriminating among levels of response in a prenatal setting. J Subst Abuse Treat. 1998; 15, 457-467. (Pubitemid 28409329)